Literature DB >> 35638820

Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression In Vitro and Prevents Lesion Formation in the Mouse Zosteriform Model.

Melkamu B Tessema1, Rubaiyea Farrukee1, Christopher E Andoniou2,3, Mariapia A Degli-Esposti2,3, Clare V Oates1, James B Barnes4, Linda M Wakim1, Andrew G Brooks1, Sarah L Londrigan1, Patrick C Reading1,4.   

Abstract

Myxovirus resistance (Mx) proteins are dynamin-like GTPases that are inducible by interferons (IFNs) following virus infections. Most studies investigating Mx proteins have focused on their activity against influenza A viruses (IAV), although emerging evidence suggests that some Mx proteins may exhibit broader antiviral activity. Herein, we demonstrate that in addition to IAV, overexpression of mouse Mx1 (mMx1), but not mMx2, resulted in potent inhibition of growth of the human alphaherpesviruses herpes simplex virus 1 (HSV-1) and HSV-2, whereas neither inhibited the mouse betaherpesvirus murine cytomegalovirus (MCMV) in vitro. IFN induction of a functional endogenous mMx1 in primary mouse fibroblasts ex vivo was also associated with inhibition of HSV-1 growth. Using an in vitro overexpression approach, we demonstrate that mutations that result in redistribution of mMx1 from the nucleus to the cytoplasm or in loss of its combined GTP binding and GTPase activity also abrogated its ability to inhibit HSV-1 growth. Overexpressed mMx1 did not inhibit early HSV-1 gene expression but was shown to inhibit both replication of the HSV-1 genome as well as subsequent late gene expression. In a mouse model of cutaneous HSV-1 infection, mice expressing a functional endogenous mMx1 showed significant reductions in the severity of skin lesions as well as reduced HSV-1 titers in both the skin and dorsal root ganglia (DRG). Together, these data demonstrate that mMx1 mediates potent antiviral activity against human alphaherpesviruses by blocking replication of the viral genome and subsequent steps in virus replication. Moreover, endogenous mMx1 potently inhibited pathogenesis in the zosteriform mouse model of HSV-1 infection. IMPORTANCE While a number of studies have demonstrated that human Mx proteins can inhibit particular herpesviruses in vitro, we are the first to report the antiviral activity of mouse Mx1 (mMx1) against alphaherpesviruses both in vitro and in vivo. We demonstrate that both overexpressed mMx1 and endogenous mMx1 potently restrict HSV-1 growth in vitro. mMx1-mediated inhibition of HSV-1 was not associated with inhibition of virus entry and/or import of the viral genome into the nucleus, but rather with inhibition of HSV-1 genomic replication as well as subsequent late gene expression. Therefore, inhibition of human alphaherpesviruses by mMx1 occurs by a mechanism that is distinct from that reported for human Mx proteins against herpesviruses. Importantly, we also provide evidence that expression of a functional endogenous mMx1 can limit HSV-1 pathogenesis in a mouse model of infection.

Entities:  

Keywords:  Mx protein; herpesviruses; host-cell interactions; innate immunity; interferons; restriction factor

Mesh:

Substances:

Year:  2022        PMID: 35638820      PMCID: PMC9215253          DOI: 10.1128/jvi.00419-22

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  58 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Gr-1+ cells, but not neutrophils, limit virus replication and lesion development following flank infection of mice with herpes simplex virus type-1.

Authors:  Magdalena Wojtasiak; Danielle L Pickett; Michelle D Tate; Sammy Bedoui; Emma R Job; Paul G Whitney; Andrew G Brooks; Patrick C Reading
Journal:  Virology       Date:  2010-11-10       Impact factor: 3.616

3.  Mouse Mx2 protein inhibits hantavirus but not influenza virus replication.

Authors:  H K Jin; K Yoshimatsu; A Takada; M Ogino; A Asano; J Arikawa; T Watanabe
Journal:  Arch Virol       Date:  2001       Impact factor: 2.574

4.  A non-cytotoxic herpes simplex virus vector which expresses Cre recombinase directs efficient site specific recombination.

Authors:  A Rinaldi; K R Marshall; C M Preston
Journal:  Virus Res       Date:  1999-12-01       Impact factor: 3.303

5.  Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle.

Authors:  J Pavlovic; O Haller; P Staeheli
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

6.  The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.

Authors:  Scott N Mueller; Claerwen M Jones; Weisan Chen; Yoshihiro Kawaoka; Maria R Castrucci; William R Heath; Francis R Carbone
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters.

Authors:  Srividya Ramachandran; Jared E Knickelbein; Christina Ferko; Robert L Hendricks; Paul R Kinchington
Journal:  Virology       Date:  2008-07-11       Impact factor: 3.616

8.  CD8(+) T-cell attenuation of cutaneous herpes simplex virus infection reduces the average viral copy number of the ensuing latent infection.

Authors:  Linda M Wakim; Claerwen M Jones; Thomas Gebhardt; Christopher M Preston; Francis R Carbone
Journal:  Immunol Cell Biol       Date:  2008-07-08       Impact factor: 5.126

9.  HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons.

Authors:  Frédéric Catez; Christel Picard; Kathrin Held; Sylvain Gross; Antoine Rousseau; Diethilde Theil; Nancy Sawtell; Marc Labetoulle; Patrick Lomonte
Journal:  PLoS Pathog       Date:  2012-08-09       Impact factor: 6.823

Review 10.  Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement.

Authors:  Dan Dou; Rebecca Revol; Henrik Östbye; Hao Wang; Robert Daniels
Journal:  Front Immunol       Date:  2018-07-20       Impact factor: 7.561

View more
  1 in total

1.  Expression of a Functional Mx1 Protein Is Essential for the Ability of RIG-I Agonist Prophylaxis to Provide Potent and Long-Lasting Protection in a Mouse Model of Influenza A Virus Infection.

Authors:  Lara S U Schwab; Fernando Villalón-Letelier; Melkamu B Tessema; Sarah L Londrigan; Andrew G Brooks; Aeron Hurt; Christoph Coch; Thomas Zillinger; Gunther Hartmann; Patrick C Reading
Journal:  Viruses       Date:  2022-07-15       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.